Style | Citing Format |
---|---|
MLA | Hassanzadeh F, et al.. "Biotin-Encoded Pullulan-Retinoic Acid Engineered Nanomicelles: Preparation, Optimization and in Vitro Cytotoxicity Assessment in Mcf-7 Cells." Indian Journal of Pharmaceutical Sciences, vol. 78, no. 5, 2016, pp. 557-565. |
APA | Hassanzadeh F, Varshosaz J, Khodarahmi GA, Rostami M, Hassanzadeh F (2016). Biotin-Encoded Pullulan-Retinoic Acid Engineered Nanomicelles: Preparation, Optimization and in Vitro Cytotoxicity Assessment in Mcf-7 Cells. Indian Journal of Pharmaceutical Sciences, 78(5), 557-565. |
Chicago | Hassanzadeh F, Varshosaz J, Khodarahmi GA, Rostami M, Hassanzadeh F. "Biotin-Encoded Pullulan-Retinoic Acid Engineered Nanomicelles: Preparation, Optimization and in Vitro Cytotoxicity Assessment in Mcf-7 Cells." Indian Journal of Pharmaceutical Sciences 78, no. 5 (2016): 557-565. |
Harvard | Hassanzadeh F et al. (2016) 'Biotin-Encoded Pullulan-Retinoic Acid Engineered Nanomicelles: Preparation, Optimization and in Vitro Cytotoxicity Assessment in Mcf-7 Cells', Indian Journal of Pharmaceutical Sciences, 78(5), pp. 557-565. |
Vancouver | Hassanzadeh F, Varshosaz J, Khodarahmi GA, Rostami M, Hassanzadeh F. Biotin-Encoded Pullulan-Retinoic Acid Engineered Nanomicelles: Preparation, Optimization and in Vitro Cytotoxicity Assessment in Mcf-7 Cells. Indian Journal of Pharmaceutical Sciences. 2016;78(5):557-565. |
BibTex | @article{ author = {Hassanzadeh F and Varshosaz J and Khodarahmi GA and Rostami M and Hassanzadeh F}, title = {Biotin-Encoded Pullulan-Retinoic Acid Engineered Nanomicelles: Preparation, Optimization and in Vitro Cytotoxicity Assessment in Mcf-7 Cells}, journal = {Indian Journal of Pharmaceutical Sciences}, volume = {78}, number = {5}, pages = {557-565}, year = {2016} } |
RIS | TY - JOUR AU - Hassanzadeh F AU - Varshosaz J AU - Khodarahmi GA AU - Rostami M AU - Hassanzadeh F TI - Biotin-Encoded Pullulan-Retinoic Acid Engineered Nanomicelles: Preparation, Optimization and in Vitro Cytotoxicity Assessment in Mcf-7 Cells JO - Indian Journal of Pharmaceutical Sciences VL - 78 IS - 5 SP - 557 EP - 565 PY - 2016 ER - |